Xgeva 120 mg/1.7 mL injection Images
Generic Name: denosumab
This medication has been identified as Xgeva 120 mg/1.7 mL injection and is used for Osteolytic Bone Metastases of Solid Tumors, Osteolytic Bone Lesions of Multiple Myeloma, Giant Cell Tumor of Bone, and Hypercalcemia of Malignancy. It belongs to the drug class miscellaneous bone resorption inhibitors and is not a controlled substance.
Images of medication
Xgeva
- Generic Name
- denosumab
- Strength
- 120 mg/1.7 mL injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous bone resorption inhibitors
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0730
See also:
More about Xgeva (denosumab)
- Check interactions
- Compare alternatives
- Reviews (10)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: miscellaneous bone resorption inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Prolia, Jubbonti, Wyost, Osenvelt, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.